SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-089939
Filing Date
2024-08-02
Accepted
2024-08-02 16:05:09
Documents
11
Period of Report
2024-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20240731.htm   iXBRL 8-K 49311
  Complete submission text file 0000950170-24-089939.txt   161875

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20240731.xsd EX-101.SCH 23892
13 EXTRACTED XBRL INSTANCE DOCUMENT meip-20240731_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 241170912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)